In the past few years, hundreds of thousands of patients have been treated with transvaginal mesh, like Johnson & Johnson’s Gynecare Prosima for the conditions of Pelvic Organ Prolapse as well as Stress Urinary Incontinence. Although these surgical mesh implants are intended to permanently remedy these medical issues, unfortunately they have been linked to the occurrence of a wide spectrum of further consequences, which are often more distressing and debilitating than either POP or SUI. After experiencing severe, expensive and painful difficulties following Gynecare Prosima treatment, many patients choose to file lawsuits against Johnson & Johnson in an attempt to receive compensation for all of their troubles related to their product.
Johnson & Johnson’s subsidiary Ethicon presented the Gynecare Prosima vaginal mesh system as a surgical solution to the conditions of Stress Urinary Incontinence and Pelvic Organ Prolapse. Both of these conditions affect women, and can negatively impact their quality of live. Gynecare Prosima works by providing additional lift and support to pelvic organs, like the bladder and urethra, in order to prevent bladder leakage and other unfortunate symptoms of these medical conditions. Johnson & Johnson also distributes various other vaginal mesh products including: Ethicon TVT, Gynecare TVT, Gynecare Prolift, and Gynemesh PS. It is important to note that the FDA has warned that the use of all transvaginal mesh treatments, including Johnson & Johnson’s Gynecare Prosima, carry an unusually high risk of complications.
According to the FDA’s official warning, one of the most common complications associated with transvaginal mesh treatment, like Gynecare Prosima, is called “mesh erosion.” Mesh erosion occurs when the materials of the Gynecare TVT grind through the walls of the vagina; needless to say it is extremely painful and requires surgical correction. Other complications associated with Gynecare Prosima treatment include vaginal discharge, pain during intercourse, pelvic discomfort, infections, and even the reoccurrence of the initial conditions of stress urinary incontinence and pelvic organ prolapse.
On 7/13/2011, the Food & Drug Administration made an official warning statement to the public as well as to health professionals regarding the high risk of using transvaginal mesh, like Johnson & Johnson’s Gynecare Prosima, in the treatment of Pelvic Organ Prolapse. Among their remarks, the FDA made it clear that in the vast majority of cases, POP can be successfully treated WITHOUT using mesh. This means that had many of the women receiving Gynecare Prosima been sufficiently warned about potential dangers, they could have chosen alternative forms of non-mesh treatment and avoided these horrific complications. Our law team at the Willis Law Firm is committed to getting you answers and financial compensation for your medical expenses, loss of income, physical pain, and emotional suffering.
If you or a loved one has suffered from the complications of using Johnson & Johnson’s Gynecare TVT for pelvic organ prolapse, a lawsuit against its producers may be the right course of action for you to pursue. The Willis Law Firm is currently reviewing and accepting cases against the makers of transvaginal mesh; please call us today. We have female consultants trained to evaluate your potential case today. All cases are handled on a Contingency Fee Basis (no attorney’s fees or expenses charged unless we recover for you).